Cardiovascular And Soft Tissue Repair Patch Market Size, Share & Trends Analysis Report By Product Type (Synthetic Patch and Biologic Patch), By Application (Soft Tissue Repair and Cardiovascular Repair), By End-Users, Region And Segment Forecasts, 2024-2031

Report Id: 1168 Pages: 190 Last Updated: 21 May 2024 Format: PDF / PPT / Excel / Power BI
Share With : linkedin twitter facebook

Global Cardiovascular & Soft Tissue Repair Patch Market Segmentation:

Global Cardiovascular & Soft Tissue Repair Patch Market By Product Type

  • Synthetic Patch
  • Biologic Patch
    • Xenogeneic Patch
    • Allogeneic Patch 

Cardiovascular And Soft Tissue Repair Patch Market

Global Cardiovascular & Soft Tissue Repair Patch Market By Application

  • Cardiovascular Repair
    • Cardiac Reconstruction
    • Vascular Reconstruction
  • Soft Tissue Repair
    • Abdominal Wall Reconstruction
    • Thoracic Wall Reconstruction
    • Dural Reconstruction
    • Hernia Repair
    • Others

Global Cardiovascular & Soft Tissue Repair Patch Market By End-user

  • Hospitals
  • Ambulatory Surgical Centers
  • Specialty Clinics

Global Cardiovascular & Soft Tissue Repair Patch Market By Region

Europe

  • Germany
  • Poland
  • France
  • Italy
  • Spain
  • UK
  • Rest of Europe

North America

  • U.S.
  • Canada

Asia Pacific

  • China
  • India
  • Japan
  • Australia
  • Rest of Asia Pacific

Latin America

  • Brazil
  • Rest of Latin America

Middle East & Africa

  • South Africa
  • Rest of Middle East & Africa

Chapter 1. Methodology and Scope

1.1. Research Methodology

1.2. Research Scope & Assumptions

Chapter 2. Executive Summary

Chapter 3. Global Cardiovascular And Soft Tissue Repair Patch Market Snapshot

Chapter 4. Global Cardiovascular And Soft Tissue Repair Patch Market Variables, Trends & Scope

4.1. Market Segmentation & Scope

4.2. Drivers

4.3. Challenges

4.4. Trends

4.5. Investment and Funding Analysis

4.6. Industry Analysis – Porter’s Five Forces Analysis

4.7. Impact of Covid-19 Analysis

Chapter 5. Market Segmentation 1: By Product Type Estimates & Trend Analysis

5.1. By Product Type & Market Share, 2023 & 2031

5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following By Product Type:

5.2.1. Synthetic Patch

5.2.2. Biologic Patch

5.2.3. Xenogeneic Patch

5.2.4. Allogeneic Patch

Chapter 6. Market Segmentation 2: By Application Estimates & Trend Analysis

6.1. By Application & Market Share, 2023 & 2031

6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following By Application:

6.2.1. Cardiovascular Repair

6.2.2. Cardiac Reconstruction

6.2.3. Vascular Reconstruction

6.2.4. Soft Tissue Repair

6.2.5. Abdominal Wall Reconstruction

6.2.6. Thoracic Wall Reconstruction

6.2.7. Dural Reconstruction

6.2.8. Hernia Repair

6.2.9. Others

Chapter 7. Market Segmentation 3: By End-User Estimates & Trend Analysis

7.1. By End-User & Market Share, 2023 & 2031

7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following By End-User:

7.2.1. Hospitals

7.2.2. Ambulatory Surgical Centers

7.2.3. Specialty Clinics

Chapter 8. Cardiovascular And Soft Tissue Repair Patch Market Segmentation 4: Regional Estimates & Trend Analysis

8.1. North America

8.1.1. North America Cardiovascular And Soft Tissue Repair Patch Market revenue (US$ Million) estimates and forecasts By Product Type, 2024 - 2031

8.1.2. North America Cardiovascular And Soft Tissue Repair Patch Market revenue (US$ Million) estimates and forecasts By Application, 2024 - 2031

8.1.3. North America Cardiovascular And Soft Tissue Repair Patch Market revenue (US$ Million) estimates and forecasts By End-User, 2024 - 2031

8.1.4. North America Cardiovascular And Soft Tissue Repair Patch Market revenue (US$ Million) estimates and forecasts by country, 2024 - 2031

8.2. Europe

8.2.1. Europe Cardiovascular And Soft Tissue Repair Patch Market revenue (US$ Million) By Product Type, 2024 - 2031

8.2.2. Europe Cardiovascular And Soft Tissue Repair Patch Market revenue (US$ Million) By Application, 2024 - 2031

8.2.3. Europe Cardiovascular And Soft Tissue Repair Patch Market revenue (US$ Million) estimates and forecasts By End-User, 2024 - 2031

8.2.4. Europe Cardiovascular And Soft Tissue Repair Patch Market revenue (US$ Million) by country, 2024 - 2031

8.3. Asia Pacific

8.3.1. Asia Pacific Cardiovascular And Soft Tissue Repair Patch Market revenue (US$ Million) By Product Type, 2024 - 2031

8.3.2. Asia Pacific Cardiovascular And Soft Tissue Repair Patch Market revenue (US$ Million) By Application, 2024 - 2031

8.3.3. Asia Pacific Cardiovascular And Soft Tissue Repair Patch Market revenue (US$ Million) estimates and forecasts By End-User, 2024 - 2031

8.3.4. Asia Pacific Cardiovascular And Soft Tissue Repair Patch Market revenue (US$ Million) by country, 2024 - 2031

8.4. Latin America

8.4.1. Latin America Cardiovascular And Soft Tissue Repair Patch Market revenue (US$ Million) By Product Type, 2024 - 2031

8.4.2. Latin America Cardiovascular And Soft Tissue Repair Patch Market revenue (US$ Million) By Application, 2024 - 2031

8.4.3. Latin America Cardiovascular And Soft Tissue Repair Patch Market revenue (US$ Million) estimates and forecasts By End-User, 2024 - 2031

8.4.4. Latin America Cardiovascular And Soft Tissue Repair Patch Market revenue (US$ Million) by country, (US$ Million) 2024 - 2031

8.5. Middle East & Africa

8.5.1. Middle East & Africa Cardiovascular And Soft Tissue Repair Patch Market revenue (US$ Million) By Product Type, 2024 - 2031

8.5.2. Middle East & Africa Cardiovascular And Soft Tissue Repair Patch Market revenue (US$ Million) By Application, 2024 - 2031

8.5.3. Middle East & Africa Cardiovascular And Soft Tissue Repair Patch Market revenue (US$ Million) estimates and forecasts By End-User, 2024 - 2031

8.5.4. Middle East & Africa Cardiovascular And Soft Tissue Repair Patch Market revenue (US$ Million) by country, (US$ Million) 2024 - 2031

Chapter 9. Competitive Landscape

9.1. Major Mergers and Acquisitions/Strategic Alliances

9.2. Company Profiles 

9.2.1. Edwards Lifesciences Corporation

9.2.2. L. Gore & Associates, Inc.

9.2.3. BD (Becton Dickinson)

9.2.4. CryoLife, Inc.

9.2.5. Baxter International, Inc.

9.2.6. Johnson & Johnson (Medical Devices Business Services, Inc.)

9.2.7. Aesculap, Inc. (a B. Braun company)

9.2.8. Nurami Medical Nanofiber Technology

9.2.9. Medtronic

9.2.10. FOC Medical S.A.

9.2.11. Admedus

9.2.12. Bone Bank Allografts

9.2.13. Braile Biomédica

9.2.14. Glycar SA Pty Ltd.

9.2.15. LeMaitre Vascular, Inc.

9.2.16. Medprin Regenerative Medical Technologies Co., Ltd.

9.2.17. CorMatrix, Inc.

9.2.18. Terumo Corporation

9.2.19. Lamed GmbH

9.2.20. South America Implants S.A.

Research Design and Approach

This study employed a multi-step, mixed-method research approach that integrates:

  • Secondary research
  • Primary research
  • Data triangulation
  • Hybrid top-down and bottom-up modelling
  • Forecasting and scenario analysis

This approach ensures a balanced and validated understanding of both macro- and micro-level market factors influencing the market.

Secondary Research

Secondary research for this study involved the collection, review, and analysis of publicly available and paid data sources to build the initial fact base, understand historical market behaviour, identify data gaps, and refine the hypotheses for primary research.

Sources Consulted

Secondary data for the market study was gathered from multiple credible sources, including:

  • Government databases, regulatory bodies, and public institutions
  • International organizations (WHO, OECD, IMF, World Bank, etc.)
  • Commercial and paid databases
  • Industry associations, trade publications, and technical journals
  • Company annual reports, investor presentations, press releases, and SEC filings
  • Academic research papers, patents, and scientific literature
  • Previous market research publications and syndicated reports

These sources were used to compile historical data, market volumes/prices, industry trends, technological developments, and competitive insights.

Secondary Research

Primary Research

Primary research was conducted to validate secondary data, understand real-time market dynamics, capture price points and adoption trends, and verify the assumptions used in the market modelling.

Stakeholders Interviewed

Primary interviews for this study involved:

  • Manufacturers and suppliers in the market value chain
  • Distributors, channel partners, and integrators
  • End-users / customers (e.g., hospitals, labs, enterprises, consumers, etc., depending on the market)
  • Industry experts, technology specialists, consultants, and regulatory professionals
  • Senior executives (CEOs, CTOs, VPs, Directors) and product managers

Interview Process

Interviews were conducted via:

  • Structured and semi-structured questionnaires
  • Telephonic and video interactions
  • Email correspondences
  • Expert consultation sessions

Primary insights were incorporated into demand modelling, pricing analysis, technology evaluation, and market share estimation.

Data Processing, Normalization, and Validation

All collected data were processed and normalized to ensure consistency and comparability across regions and time frames.

The data validation process included:

  • Standardization of units (currency conversions, volume units, inflation adjustments)
  • Cross-verification of data points across multiple secondary sources
  • Normalization of inconsistent datasets
  • Identification and resolution of data gaps
  • Outlier detection and removal through algorithmic and manual checks
  • Plausibility and coherence checks across segments and geographies

This ensured that the dataset used for modelling was clean, robust, and reliable.

Market Size Estimation and Data Triangulation

Bottom-Up Approach

The bottom-up approach involved aggregating segment-level data, such as:

  • Company revenues
  • Product-level sales
  • Installed base/usage volumes
  • Adoption and penetration rates
  • Pricing analysis

This method was primarily used when detailed micro-level market data were available.

Bottom Up Approach

Top-Down Approach

The top-down approach used macro-level indicators:

  • Parent market benchmarks
  • Global/regional industry trends
  • Economic indicators (GDP, demographics, spending patterns)
  • Penetration and usage ratios

This approach was used for segments where granular data were limited or inconsistent.

Hybrid Triangulation Approach

To ensure accuracy, a triangulated hybrid model was used. This included:

  • Reconciling top-down and bottom-up estimates
  • Cross-checking revenues, volumes, and pricing assumptions
  • Incorporating expert insights to validate segment splits and adoption rates

This multi-angle validation yielded the final market size.

Forecasting Framework and Scenario Modelling

Market forecasts were developed using a combination of time-series modelling, adoption curve analysis, and driver-based forecasting tools.

Forecasting Methods

  • Time-series modelling
  • S-curve and diffusion models (for emerging technologies)
  • Driver-based forecasting (GDP, disposable income, adoption rates, regulatory changes)
  • Price elasticity models
  • Market maturity and lifecycle-based projections

Scenario Analysis

Given inherent uncertainties, three scenarios were constructed:

  • Base-Case Scenario: Expected trajectory under current conditions
  • Optimistic Scenario: High adoption, favourable regulation, strong economic tailwinds
  • Conservative Scenario: Slow adoption, regulatory delays, economic constraints

Sensitivity testing was conducted on key variables, including pricing, demand elasticity, and regional adoption.

Name field cannot be blank!
Email field cannot be blank!(Use email format)
Designation field cannot be blank!
Company field cannot be blank!
Contact No field cannot be blank!
Message field cannot be blank!
7320
Security Code field cannot be blank!

Frequently Asked Questions

The Cardiovascular And Soft Tissue Repair Patch Market Size is valued at 4063.5 Mn in 2023 and it is predicted to reach 8139.6 Mn by the yea

The Cardiovascular And Soft Tissue Repair Patch Market is expected to grow at an 9.25% CAGR during the forecast period for 2024-2031.

Edwards Lifesciences Corporation, BD (Becton Dickinson), W. L. Gore & Associates, Inc., CryoLife, Inc., Baxter International, Inc., Aesculap, Inc. (a

Report License Selection

Determine the Appropriate License for your Report

Get Sample Report Enquiry Before Buying